ALPANA JAYADEVAN: Open Payments
NPI 1386277036 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,990 in 99 payments from 21 companies in 2025. Trend: 2023 $3,728 · 2024 $5,379 · 2025 $4,990
Consulting: $2,750Food & beverage: $2,140Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $3,114 |
| Janssen Biotech, Inc. | 10 | $320 |
| Amgen Inc. | 14 | $284 |
| Mallinckrodt Hospital Products Inc. | 9 | $273 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| UCB, Inc. | 8 | $152 |
| PFIZER INC. | 5 | $98 |
| Invivyd Inc | 4 | $97 |
| ANI Pharmaceuticals, Inc. | 3 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
Products named: TREMFYA, RINVOQ, ACTHAR, COSENTYX, Bimzelx, KRYSTEXXA, XELJANZ, PEMGARDA.
Industry payments across CA — which companies pay providers there.
